↓ Skip to main content

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

Overview of attention for article published in BMC Infectious Diseases, August 2012
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
31 Mendeley